New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTVIVO, VIVO, VIVO, VRML, VRML, VRML, SYK, SYK, SYK, SNY, SNY, SNY, RHHBY, RHHBY, RHHBY, QGEN, QGEN, QGEN, PFE, PFE, PFE, MRK, MRK, MRK, LG, LG, LG, EXAS, EXAS, EXAS, COV, COV, COV, CYH, CYH, CYH, CPHD, CPHD, CPHD, BAYRY, BAYRY, BAYRY, ATHN, ATHN, ATHN, ABBV, ABBV, ABBV, A, A, AAmerican College of Obstetricians & Gynecologists to hold annual meeting
2104 Annual Clinical Meeting of ACOG is being held in Chicago on April 26-30.
News For A;ABBV;ATHN;BAYRY;CPHD;CYH;COV;EXAS;LG;MRK;PFE;QGEN;RHHBY;SNY;SYK;VRML;VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 20, 2015
10:00 EDTBAYRYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:26 EDTVIVOMeridican says illumigene receives FDA clearance
Meridian Bioscience announced that it has received FDA clearance for two new molecular assays for the detection of Herpes Simplex Virus Type 1 and Type 2, to be run on its illumigene molecular platform. The illumigene HSV 1&2 assays, launched earlier this year in Europe, are now available immediately in the U.S.
09:22 EDTEXASOn The Fly: Pre-market Movers
Subscribe for More Information
08:38 EDTBAYRYAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
08:04 EDTSYKStryker announces definitive agreement tyo acquire Muka Metal
Stryker announced a definitive agreement to acquire Muka Metal, A.S. in an all cash transaction. Muka, headquartered in Kayseri, Turkey, sells hospital beds, stretchers and related patient room furniture and accessories that serve markets across Turkey and other regions globally. Upon closing, the transaction is expected to be neutral to Stryker's FY15 EPS excluding acquisition, integration-related and intangible amortization charges and accretive thereafter. The transaction is expected to close in Q3.
07:33 EDTCPHD, RHHBYInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTBAYRYZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
06:17 EDTCPHDMizuho sees Q2 earnings beats in Diagnostics space
Subscribe for More Information
05:32 EDTEXASExact Sciences reports Q2 EPS (44c), consensus (45c)
Reports Q2 revenue $8.1M, consensus $7.96M.
05:21 EDTBAYRYBayer downgraded to Hold from Buy at Jefferies
Subscribe for More Information
05:13 EDTRHHBYRoche expands HIV Global Access Program
Roche announced an expansion to the HIV Global Access Program to include early infant HIV diagnostic testing for low and middle income countries. Roche, in partnership with the Joint United Nations Programme on HIV/AIDS, or UNAIDS, the Clinton Health Access Initiative, or CHAI, UNITAID, the U.S. President's Emergency Plan For AIDS Relief, or PEPFAR, and the Global Fund to fight AIDS, TB and Malaria, is committed to working with the Diagnostics Access Initiative by providing state-of-the-art solutions to achieve the 90-90-90 goal set forth by UNAIDS. Announced in 2014, the HIV Global Access Program is Roche's most recent addition to the AmpliCare Initiative, which launched in 2002 in South Africa.
July 17, 2015
09:04 EDTABBVAbbVie granted FDA orphan status for Viekira Pak in pediatric patients
Subscribe for More Information
08:06 EDTABBVAbbVie, C2N Diagnostics announce orphan drug designation of C2N-8E12
Subscribe for More Information
July 16, 2015
16:00 EDTPFEOptions Update; July 16, 2015
iPath S&P 500 VIX Short-Term Futures down 1.17 to 16.52 Option volume leaders: NFLX AAPL BAC FB F INTC C EBAY AMZN GM JPM MU PFE BABA JD X
10:00 EDTATHNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTCYHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:36 EDTCYHCommunity Health downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc downgraded Community Health to Sector Weight based on valuation and limited opportunities for upside to earnings growth.
06:15 EDTATHNathenahealth initiated with a Hold at Canaccord
Target $125.
July 15, 2015
08:04 EDTPFEPfizer treatment of CIDP granted FDA orphan status
Subscribe for More Information
07:29 EDTSYKAmerican Orthopaedic Foot & Ankle Society to hold annual meeting
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use